JERRICA TRUJILLO: Open Payments
NPI 1407254303 · LAS CRUCES, NM. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$892 in 34 payments from 10 companies in 2025. Trend: 2023 $737 · 2024 $717 · 2025 $892
Food & beverage: $892
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 4 | $225 |
| Insulet Corporation | 7 | $213 |
| Lilly USA, LLC | 4 | $89 |
| ABBVIE INC. | 3 | $80 |
| Xeris Pharmaceuticals, Inc. | 4 | $73 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $66 |
| AstraZeneca Pharmaceuticals LP | 4 | $63 |
| Novo Nordisk Inc | 3 | $48 |
| ABIOMED | 1 | $20 |
| Exact Sciences Corporation | 1 | $16 |
Products named: FREESTYLE LIBRE 3, Omnipod, VRAYLAR, GVOKE HYPOPEN, CAPLYTA, JARDIANCE, Wegovy, AIRSUPRA.
Industry payments across NM — which companies pay providers there.
